MIDATECH PHARMA
News | News 2013
Nov 5, 2013
Midatech Raises £10 Million to Advance Gold-nanoparticle Technology for Diabetes and Cancer Treatment

Abingdon, UK, 5 November 2013 – Midatech Ltd., a global leader in the design, synthesis and manufacture of nanomedicines based... read more >

Sep 23, 2013
MidaSol™ Therapeutics LP Signs Research Collaboration

Abingdon, UK, 23 September 2013 – MidaSol™ Therapeutics LP, the strategic joint venture formed between Midatech Ltd, a global... read more >

Sep 16, 2013
Midatech appoints Dr Jim Phillips as Chief Executive Officer

Midatech Ltd., a global leader in the design, synthesis and manufacture of nanomedicines based on its unique gold-nanoparticle (GNP) drug... read more >

 

News
News 2013
Nov 5, 2013
Midatech Raises £10 Million to Advance Gold-nanoparticle Technology for Diabetes and Cancer Treatment

Abingdon, UK, 5 November 2013 – Midatech Ltd., a global leader in the design, synthesis and manufacture of nanomedicines based... read more >

Sep 23, 2013
MidaSol™ Therapeutics LP Signs Research Collaboration

Abingdon, UK, 23 September 2013 – MidaSol™ Therapeutics LP, the strategic joint venture formed between Midatech Ltd, a global... read more >

Sep 16, 2013
Midatech appoints Dr Jim Phillips as Chief Executive Officer

Midatech Ltd., a global leader in the design, synthesis and manufacture of nanomedicines based on its unique gold-nanoparticle (GNP) drug... read more >

© Copyright 2017 Midatech Pharma PLC